Literature DB >> 25142587

Human papillomavirus type 1 E1^E4 protein is a potent inhibitor of the serine-arginine (SR) protein kinase SRPK1 and inhibits phosphorylation of host SR proteins and of the viral transcription and replication regulator E2.

Emma L Prescott1, Claire L Brimacombe1, Margaret Hartley1, Ian Bell1, Sheila Graham2, Sally Roberts3.   

Abstract

UNLABELLED: The serine-arginine-specific protein kinase SRPK1 is a common binding partner of the E1^E4 protein of diverse human papillomavirus types. We show here for the first time that the interaction between HPV1 E1^E4 and SRPK1 leads to potent inhibition of SRPK1 phosphorylation of host serine-arginine (SR) proteins that have critical roles in mRNA metabolism, including pre-mRNA processing, mRNA export, and translation. Furthermore, we show that SRPK1 phosphorylates serine residues of SR/RS dipeptides in the hinge region of the HPV1 E2 protein in in vitro kinase assays and that HPV1 E1^E4 inhibits this phosphorylation. After mutation of the putative phosphoacceptor serine residues, the localization of the E2 protein was altered in primary human keratinocytes; with a significant increase in the cell population showing intense E2 staining of the nucleolus. A similar effect was observed following coexpression of E2 and E1^E4 that is competent for inhibition of SRPK1 activity, suggesting that the nuclear localization of E2 is sensitive to E1^E4-mediated SRPK1 inhibition. Collectively, these data suggest that E1^E4-mediated inhibition of SRPK1 could affect the functions of host SR proteins and those of the virus transcription/replication regulator E2. We speculate that the novel E4 function identified here is involved in the regulation of E2 and SR protein function in posttranscriptional processing of viral transcripts. IMPORTANCE: The HPV life cycle is tightly linked to the epithelial terminal differentiation program, with the virion-producing phase restricted to differentiating cells. While the most abundant HPV protein expressed in this phase is the E4 protein, we do not fully understand the role of this protein. Few E4 interaction partners have been identified, but we had previously shown that E4 proteins from diverse papillomaviruses interact with the serine-arginine-specific protein kinase SRPK1, a kinase important in the replication cycles of a diverse range of DNA and RNA viruses. We show that HPV1 E4 is a potent inhibitor of this host cell kinase. We show that E4 inhibits SRPK1 phosphorylation, not only of cellular SR proteins involved in regulating alternative splicing of RNA but also the viral transcription/replication regulator E2. Our findings reveal a potential E4 function in regulation of viral late gene expression through the inhibition of a host cell kinase.
Copyright © 2014, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25142587      PMCID: PMC4248925          DOI: 10.1128/JVI.02029-14

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  65 in total

1.  Specific interaction between HPV-16 E1-E4 and cytokeratins results in collapse of the epithelial cell intermediate filament network.

Authors:  J Doorbar; S Ely; J Sterling; C McLean; L Crawford
Journal:  Nature       Date:  1991-08-29       Impact factor: 49.962

2.  Role of calpain in the formation of human papillomavirus type 16 E1^E4 amyloid fibers and reorganization of the keratin network.

Authors:  Jameela Khan; Clare E Davy; Pauline B McIntosh; Deborah J Jackson; Steven Hinz; Qian Wang; John Doorbar
Journal:  J Virol       Date:  2011-07-13       Impact factor: 5.103

3.  Phosphorylation of the human papillomavirus type 1 E4 proteins in vivo and in vitro.

Authors:  R J Grand; J Doorbar; K J Smith; I Coneron; P H Gallimore
Journal:  Virology       Date:  1989-05       Impact factor: 3.616

4.  Utilization of host SR protein kinases and RNA-splicing machinery during viral replication.

Authors:  Takeshi Fukuhara; Takamitsu Hosoya; Saki Shimizu; Kengo Sumi; Takako Oshiro; Yoshiyuki Yoshinaka; Masaaki Suzuki; Naoki Yamamoto; Leonore A Herzenberg; Leonard A Herzenberg; Masatoshi Hagiwara
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-13       Impact factor: 11.205

5.  Phosphorylation of the human papillomavirus type 16 E1--E4 protein at T57 by ERK triggers a structural change that enhances keratin binding and protein stability.

Authors:  Qian Wang; Alan Kennedy; Papia Das; Pauline B McIntosh; Steven A Howell; Erin R Isaacson; Steven A Hinz; Clare Davy; John Doorbar
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

6.  Identification of SRPK1 and SRPK2 as the major cellular protein kinases phosphorylating hepatitis B virus core protein.

Authors:  Henrik Daub; Stephanie Blencke; Peter Habenberger; Alexander Kurtenbach; Julia Dennenmoser; Josef Wissing; Axel Ullrich; Matt Cotten
Journal:  J Virol       Date:  2002-08       Impact factor: 5.103

7.  Interaction between human papillomavirus type 5 E2 and polo-like kinase 1.

Authors:  Wei-Sheng Wang; Moon-Sing Lee; Chih-En Tseng; I-Huan Liao; Shu-Ping Huang; Ru-Inn Lin; Chin Li
Journal:  J Med Virol       Date:  2009-03       Impact factor: 2.327

8.  Purification and characterization of a kinase specific for the serine- and arginine-rich pre-mRNA splicing factors.

Authors:  J F Gui; H Tronchère; S D Chandler; X D Fu
Journal:  Proc Natl Acad Sci U S A       Date:  1994-11-08       Impact factor: 11.205

9.  Analysis of HPV-1 E4 gene expression using epitope-defined antibodies.

Authors:  J Doorbar; H S Evans; I Coneron; L V Crawford; P H Gallimore
Journal:  EMBO J       Date:  1988-03       Impact factor: 11.598

10.  Human papillomavirus type 16 E2 protein transcriptionally activates the promoter of a key cellular splicing factor, SF2/ASF.

Authors:  Sarah Mole; Steven G Milligan; Sheila V Graham
Journal:  J Virol       Date:  2008-10-22       Impact factor: 5.103

View more
  22 in total

Review 1.  The diverse functions of the hepatitis B core/capsid protein (HBc) in the viral life cycle: Implications for the development of HBc-targeting antivirals.

Authors:  Ahmed Diab; Adrien Foca; Fabien Zoulim; David Durantel; Ourania Andrisani
Journal:  Antiviral Res       Date:  2017-11-26       Impact factor: 5.970

2.  Human Papillomavirus 31 Tyrosine 102 Regulates Interaction with E2 Binding Partners and Episomal Maintenance.

Authors:  Timra Gilson; Sara Culleton; Fang Xie; Marsha DeSmet; Elliot J Androphy
Journal:  J Virol       Date:  2020-07-30       Impact factor: 5.103

3.  A proteomic approach to discover and compare interacting partners of papillomavirus E2 proteins from diverse phylogenetic groups.

Authors:  Moon Kyoo Jang; D Eric Anderson; Koenraad van Doorslaer; Alison A McBride
Journal:  Proteomics       Date:  2015-04-28       Impact factor: 3.984

Review 4.  RNA Binding Proteins that Control Human Papillomavirus Gene Expression.

Authors:  Naoko Kajitani; Stefan Schwartz
Journal:  Biomolecules       Date:  2015-05-05

5.  Molecular characterization, tissue tropism, and genetic variability of the novel Mupapillomavirus type HPV204 and phylogenetically related types HPV1 and HPV63.

Authors:  Anja Šterbenc; Lea Hošnjak; Diego Chouhy; Elisa M Bolatti; Anja Oštrbenk; Katja Seme; Boštjan J Kocjan; Boštjan Luzar; Adriana A Giri; Mario Poljak
Journal:  PLoS One       Date:  2017-04-20       Impact factor: 3.240

Review 6.  Control of human papillomavirus gene expression by alternative splicing.

Authors:  Sheila V Graham; Arwa Ali A Faizo
Journal:  Virus Res       Date:  2016-11-17       Impact factor: 3.303

7.  A proposed role for the SARS-CoV-2 nucleocapsid protein in the formation and regulation of biomolecular condensates.

Authors:  Sean M Cascarina; Eric D Ross
Journal:  FASEB J       Date:  2020-06-20       Impact factor: 5.191

8.  A Multi-Breed Genome-Wide Association Analysis for Canine Hypothyroidism Identifies a Shared Major Risk Locus on CFA12.

Authors:  Matteo Bianchi; Stina Dahlgren; Jonathan Massey; Elisabeth Dietschi; Marcin Kierczak; Martine Lund-Ziener; Katarina Sundberg; Stein Istre Thoresen; Olle Kämpe; Göran Andersson; William E R Ollier; Åke Hedhammar; Tosso Leeb; Kerstin Lindblad-Toh; Lorna J Kennedy; Frode Lingaas; Gerli Rosengren Pielberg
Journal:  PLoS One       Date:  2015-08-11       Impact factor: 3.240

9.  The human papillomavirus type 16 L1 protein directly interacts with E2 and enhances E2-dependent replication and transcription activation.

Authors:  Abida Siddiqa; Karen Campos Léon; Claire D James; Muhammad Faraz Bhatti; Sally Roberts; Joanna L Parish
Journal:  J Gen Virol       Date:  2015-04-24       Impact factor: 3.891

10.  Serine-arginine protein kinase 1 (SRPK1) is elevated in gastric cancer and plays oncogenic functions.

Authors:  Xiaotao Xu; Yuehua Wei; Shidong Wang; Man Luo; Heng Zeng
Journal:  Oncotarget       Date:  2017-06-28
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.